AAAAAA
Results:
1-13
|
Results: 13
Authors:
Peters, WP
Citation: Wp. Peters, Transplant registries: Guiding clinical decisions and improving outcomes -The Horowitz et al article reviewed, ONCOLOGY-NY, 15(5), 2001, pp. 666-666
Authors:
Baynes, RD
Dansey, RD
Klein, JL
Hamm, C
Campbell, M
Abella, E
Peters, WP
Citation: Rd. Baynes et al., High-dose chemotherapy and hematopoietic stem cell transplantation for breast cancer: Past or future?, SEMIN ONCOL, 28(4), 2001, pp. 377-388
Authors:
Peters, WP
Baynes, RB
Cassells, L
Dansey, R
Klein, J
Hamm, C
Karanes, C
Abella, S
Citation: Wp. Peters et al., The Dix/Geller article reviewed, ONCOLOGY-NY, 14(2), 2000, pp. 191-192
Authors:
Baynes, RD
Dansey, RD
Klein, JL
Karanes, C
Cassells, L
Abella, E
Wei, WZ
Galy, A
Du, W
Wood, G
Peters, WP
Citation: Rd. Baynes et al., High-dose chemotherapy and autologous stem cell transplantation for breastcancer, CANCER INV, 18(5), 2000, pp. 440-455
Authors:
Klein, JL
Rey, PM
Dansey, RD
Karanes, C
Du, W
Abella, E
Cassells, L
Hamm, C
Peters, WP
Baynes, RD
Citation: Jl. Klein et al., Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer, BONE MAR TR, 25(10), 2000, pp. 1047-1052
Authors:
Baynes, RD
Hamm, C
Dansey, R
Klein, J
Cassells, L
Karanes, C
Abella, E
Peters, WP
Citation: Rd. Baynes et al., Bone marrow and peripheral blood hematopoietic stem cell transplantation: Focus on autografting, CLIN CHEM, 46(8B), 2000, pp. 1239-1251
Authors:
Du, W
Touchette, D
Vaitkevicius, VK
Peters, WP
Shields, AF
Citation: W. Du et al., Cost analysis of pancreatic carcinoma treatment, CANCER, 89(9), 2000, pp. 1917-1924
Authors:
Bronchud, MH
Peters, WP
Citation: Mh. Bronchud et Wp. Peters, Selecting the right targets for cancer therapy, PRINCIPLES OF MOLECULAR ONCOLOGY, 2000, pp. 3-27
Authors:
Carter, DL
Marks, LB
Bean, JM
Broadwater, G
Hussein, A
Vredenburgh, JJ
Peters, WP
Prosnitz, LR
Citation: Dl. Carter et al., Impact of consolidation radiotherapy in patients with advanced breast cancer treated with high-dose chemotherapy and autologous bone marrow rescue, J CL ONCOL, 17(3), 1999, pp. 887-893
Authors:
Rizzieri, DA
Vredenburgh, JJ
Jones, R
Ross, M
Shpall, EJ
Hussein, A
Broadwater, G
Berry, D
Petros, WP
Gilbert, C
Affronti, ML
Coniglio, D
Rubin, P
Elkordy, M
Long, GD
Chao, NJ
Peters, WP
Citation: Da. Rizzieri et al., Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support, J CL ONCOL, 17(10), 1999, pp. 3064-3074
Authors:
Klein, JL
Rey, PM
Dansey, R
Karanes, C
Abella, E
Cassells, L
Hamm, C
Flowers, M
Couwlier, C
Peters, WP
Baynes, RD
Citation: Jl. Klein et al., Cyclophosphamide and paclitaxel as initial or salvage regimen for the mobilization of peripheral blood progenitor cells, BONE MAR TR, 24(9), 1999, pp. 959-963
Authors:
Bearman, SI
Vredenburh, JJ
Cagnoni, PJ
Shpall, EJ
Nieto, Y
Ross, M
Peters, WP
Jones, RB
Citation: Si. Bearman et al., High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy, BONE MAR TR, 24(5), 1999, pp. 491-495
Authors:
Vredenburgh, J
Fishman, R
Coniglio, D
Matters, L
Elkordy, M
Ross, M
Hussein, A
Rubin, P
Gilbert, C
Petros, W
Peters, WP
Citation: J. Vredenburgh et al., The addition of paclitaxel to continuous infusion 5-fluorouracil is an active regimen for metastatic breast cancer, AM J CL ONC, 21(6), 1998, pp. 543-547
Risultati:
1-13
|